Updates are available Correction dated 2023-05-09

Article History

Received: 7 October 2021

Accepted: 1 December 2021

First Online: 10 December 2021

Change Date: 9 May 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s40035-023-00351-3

Declarations

:

: All procedures in the study were approved by the Hospital de Sant Pau ethics committee. All participants provided written informed consent.

: Not applicable.

: Nuole Zhu is employed by Hospital de la Santa Creu i Sant Pau. Declarations of interest: none. Miguel Santos is employed by Hospital de la Santa Creu i Sant Pau. He is funded by a “Juan Rodés” research grant from the Institute of Health Carlos III. Ignasio Illán-Gala is supported by the Global Brain Health Institute (Atlantic Fellow for Equity in Brain Health and pilot award for global brain health leaders CBHI ALZ UK-21-720973) and the “Juan Rodés” grant from the Institute of Health Carlos III /JR20/00018). Victor Montal is employed by the Biomedical Research Institute Sant Pau. Declarations of interest: none. Teresa Estellés is employed by Biomedical Research Institute Sant Pau. Declarations of interest: Dr. Estellés is funded by a “Río Hortega” research grant from the Institute of Health Carlos III. Isabel Barroeta is employed by Hospital de la Santa Creu i Sant Pau. Declarations of interest: none. Miren Altuna is employed by Biomedical Research Institute Sant Pau. Declarations of interest: Dr. Estellés is funded by a “Río Hortega” research grant from the Institute of Health Carlos III. Javier Arranz is employed by Biomedical Research Institute Sant Pau. Declarations of interest: none. Laia Muñoz is employed by Biomedical Research Institute Sant Pau. Declarations of interest: none. Olivia Belbin is employed by Biomedical Research Institute Sant Pau. Dr. Belbin is funded by a “Miguel Servet” research grant from the Institute of Health Carlos III. Isabel Sala is employed by Hospital de la Santa Creu i Sant Pau. Declarations of interest: none. M. Belén Sánchez-Saudinós is employed by the Biomedical Research Institute Sant Pau. Declarations of interest: none. Andrea Subirana is employed by the Biomedical Research Institute Sant Pau. Declarations of interest: none. Laura Videla is employed by Fundació Catalana Síndrome de Down. Declarations of interest: none. Jordi Pegueroles is employed by the Biomedical Research Institute Sant Pau. Declarations of interest: none. Rafael Blesa is employed by Hospital de la Santa Creu i Sant Pau and received research grants from Institute of Health Carlos III, Fundació Bancària Obra Social La Caixa and Fundació La Marató de TV3. He participated in advisory boards from Lilly and Nutricia, and he received speakers honoraria and travel funding from Novartis and Nutricia. Jordi Clarimón is employed by Biomedical Research Institute Sant Pau and received research grants from Generalitat de Catalunya and from Institute of Health Carlos III. Maria Carmona-Iragui is employed by Hospital de la Santa Creu i Sant Pau. Declarations of interest: none. Juan Fortea is employed by Hospital de la Santa Creu i Sant Pau and received research grants from Institute of Health Carlos III, Fundació La Marató de TV3, and Pla Estratègic de Recerca i Innovació en Salut (PERIS). Alberto LLeó is employed by Hospital de la Santa Creu i Sant Pau and received research grants from CIBERNED, Institute of Health Carlos III and Fundació BBVA. He participated in advisory boards from Fujirebio-Europe, Nutricia, Biogen and received speaker honoraria from Lilly. Daniel Alcolea is employed by Hospital de la Santa Creu i Sant Pau and received research grants from Pla Estratègic de Recerca i Innovació en Salut (PERIS SLT006/17/125), and from Institute of Health Carlos III (PI18/00435 and INT19/00016). He participated in advisory boards from Fujirebio-Europe and Roche Diagnostics and received speaker honoraria from Fujirebio-Europe, Roche Diagnostic, Nutricia, Esteve and from Krka Farmacéutica S.L.